(The Center Square) – Medicare Part D sponsors made $587.7 million in ineligible payments to pharmacies for five drugs carrying obsolete prescription-only labeling more than a year after the corresponding brand-name drugs switched to over-the-counter status, a federal watchdog found.
From
To
US President Donald Trump's order aims to foster a more competitive prescription drug market
US President Donald Trump signed an executive order Tuesday aiming to lower crippling drug prices by giving states more leeway to bargain-hunt…
Young man pressing fingers to his jaw, trying to overcome severe toothache, eyes closed, isolated on gray background
At a time when Alabama and other states are seeing a surge in fentanyl overdose deaths, Alabama doctors say increasing access to naloxone will…